Latest Insider Transactions at Ultragenyx Pharmaceutical Inc. (RARE)
This section provides a real-time view of insider transactions for Ultragenyx Pharmaceutical Inc. (RARE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ultragenyx Pharmaceutical Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ultragenyx Pharmaceutical Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 14
2020
|
Erik Harris EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
220
-0.93%
|
$19,360
$88.0 P/Share
|
|
Oct 14
2020
|
Thomas Richard Kassberg CBO & EVP |
SELL
Open market or private sale
|
Direct |
262
-0.26%
|
$22,794
$87.98 P/Share
|
|
Oct 14
2020
|
Karah Herdman Parschauer EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
325
-1.34%
|
$28,600
$88.0 P/Share
|
|
Oct 14
2020
|
Camille L Bedrosian EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
262
-0.73%
|
$23,056
$88.0 P/Share
|
|
Oct 14
2020
|
Emil D Kakkis President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
852
-0.14%
|
$78,384
$92.69 P/Share
|
|
Oct 12
2020
|
Mardi Dier CFO & Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Oct 12
2020
|
John Richard Pinion |
SELL
Open market or private sale
|
Direct |
2,780
-5.63%
|
$261,320
$94.47 P/Share
|
|
Oct 08
2020
|
Karah Herdman Parschauer EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-29.16%
|
$950,000
$95.0 P/Share
|
|
Oct 08
2020
|
Karah Herdman Parschauer EVP and Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.58%
|
$540,000
$54.5 P/Share
|
|
Oct 06
2020
|
Karah Herdman Parschauer EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-29.16%
|
$900,000
$90.0 P/Share
|
|
Oct 06
2020
|
Karah Herdman Parschauer EVP and Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.58%
|
$480,000
$48.43 P/Share
|
|
Jun 03
2020
|
Erik Harris EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,516
-10.77%
|
$186,184
$74.69 P/Share
|